News

Outlook typing lag will finally get a fix from Microsoft
Rolling classic Outlook back to version 2405 seems to fix the issue, but it comes with a not-insignificant tradeoff. Updates ...
Microsoft will fix classic Outlook typing lag in the coming weeks
There's a bug in classic Outlook that causes CPU spikes while typing. Here's a workaround you can use until it's fixed.
Microsoft announces fix for CPU spikes when typing in Outlook
Microsoft says it will soon fix a known issue causing CPU spikes when typing messages in recent versions of its classic ...
You'll hate Microsoft's new Outlook less — after facing an annoying Outlook Classic bug cranking CPU usage to 50% in Windows 11 when typing
Microsoft recently acknowledged a critical bug impacting Outlook Classic users. The company indicated that the bug causes an ...
Bleeping Computer15d
Microsoft releases emergency update to fix Office 2016 crashes
and Outlook to crash after installing the KB5002700 security update for Office 2016. The company acknowledged these problems following user reports on social media that Office apps no longer open ...
Windows Latest17d
KB5002700 crashes Office 2016 Word, Excel, Outlook on Windows
Outlook is working fine,” one user noted ... After removing the update, you’ll be able to use Office 2016 apps again. We do not recommend installing the April 2025 patch for Office 2016 ...
ophthalmologytimes17d
FDA accepts biologics license application from Outlook Therapeutics for ONS-5010 for the treatment of wet AMD
The FDA accepted the resubmission of the BLA for ONS-5010, classifying it as a Class 2 review with a PDUFA date of August 27, 2025. The resubmission follows a complete response letter citing CMC ...
Seeking Alpha17d
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics ... receipt of the resubmission of the Biologics License Application (BLA) for ONS-5010 (bevacizumab-vikg), an investigational ...
Yahoo Finance18d
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics ... the Biologics License Application (BLA) for ONS ...
Yahoo Finance18d
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics ... receipt of the resubmission of the Biologics License ...
manilatimes18d
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook ...
TMCnet18d
Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
ISELIN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics ... has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for ONS-5010 (bevacizumab-vikg), an ...